PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-0.04%
Revenue decline while VET shows 14.00% growth. Joel Greenblatt would examine competitive position erosion.
11.95%
Cost growth 50-75% of VET's 20.99%. Bruce Berkowitz would examine sustainable cost advantages.
-10.64%
Gross profit decline while VET shows 10.50% growth. Joel Greenblatt would examine competitive position.
-10.61%
Both companies show margin pressure. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
11.91%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
8.75%
Operating expenses growth above 1.5x VET's 0.71%. Michael Burry would check for inefficiency.
11.04%
Similar total costs growth to VET's 10.30%. Walter Schloss would investigate norms.
No Data
No Data available this quarter, please select a different quarter.
10.84%
D&A growth above 1.5x VET's 1.74%. Michael Burry would check for excessive investment.
-11.07%
EBITDA decline while VET shows 11.89% growth. Joel Greenblatt would examine position.
-9.45%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-21.50%
Operating income decline while VET shows 22.86% growth. Joel Greenblatt would examine position.
-21.47%
Operating margin decline while VET shows 7.78% growth. Joel Greenblatt would examine position.
-44.50%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-25.22%
Both companies show declining income. Martin Whitman would check industry conditions.
-25.19%
Both companies show margin pressure. Martin Whitman would check industry conditions.
14.59%
Tax expense growth while VET reduces burden. John Neff would investigate differences.
-35.24%
Net income decline while VET shows 18.49% growth. Joel Greenblatt would examine position.
-35.21%
Net margin decline while VET shows 3.94% growth. Joel Greenblatt would examine position.
-34.91%
EPS decline while VET shows 17.74% growth. Joel Greenblatt would examine position.
-34.22%
Diluted EPS decline while VET shows 18.33% growth. Joel Greenblatt would examine position.
-7.58%
Both companies reducing share counts. Martin Whitman would check patterns.
-7.72%
Diluted share reduction while VET shows 0.83% change. Joel Greenblatt would examine strategy.